舒泰神 (300204.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−178.7x

Market Cap

CNY 11.37B

MomentumView details →

1D Return

−5.32%

YTD Return

−23.35%

RSI (14)

40.2

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−178.7x

Market Cap

CNY 11.37B

RSI (14)

40.2

MomentumView details →

1D Return

−5.32%

YTD Return

−23.35%

ProfitabilityView details →

Gross Margin

77.17%

Net Margin

−41.12%

EBITDA Margin

−31.05%

ROE (TTM)

−10.36%

ROA (TTM)

−6.55%

Asset Turnover

0.16x

GrowthView details →

Revenue YoY

−30.42%

EPS YoY

+41.45%

FCF YoY

—

Revenue CAGR 3Y

−26.25%

EPS CAGR 3Y

+46.67%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.15x

Current Ratio

2.00x

Quick Ratio

1.85x

Div Yield

—

Div Rate

—

Div Growth 1Y

+167.23%

Financials snapshotView financials →

Revenue (TTM)

203.92M

Net Income (TTM)

−83.86M

Op. CF (TTM)

−130.31M

Latest newsMore news →

Shutaishen announced that Bai Xuelian, general manager of its clinical research center, resigned for personal reasons and will no longer hold any position in the company.33d ago

Similar companies

利尔化学002258.SZ 宝武镁业002182.SZ 平潭发展000592.SZ 石药景峰000908.SZ 奥飞娱乐002292.SZ 四川九洲000801.SZ Find similar companies →

Latest newsMore news →

Shutaishen announced that Bai Xuelian, general manager of its clinical research center, resigned for personal reasons and will no longer hold any position in the company.33d ago